loader
Please Wait
Applying Filters...

Annual Sales of Nilotinib Hydrochloride reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 4,817Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Tasigna

PharmaCompass

01

Brand Name : Tasigna

Nilotinib

arrow
Luxepack
Not Confirmed

02

Brand Name : Tasigna

Nilotinib

arrow
Luxepack
Not Confirmed

03

Brand Name : Tasigna

Nilotinib

arrow
Luxepack
Not Confirmed

Brand Name : Tasigna

arrow
Luxepack
Not Confirmed

Nilotinib

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 1,923

2021 Revenue in Millions : 2,060

Growth (%) : -7

blank

04

Brand Name : Tasigna

Nilotinib

arrow
Luxepack
Not Confirmed

05

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
Luxepack
Not Confirmed

06

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
Luxepack
Not Confirmed

07

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
Luxepack
Not Confirmed

08

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
Luxepack
Not Confirmed

09

Brand Name : Tasigna

Nilotinib Hydrochloride

arrow
Luxepack
Not Confirmed

10

Brand Name : Tasigna

Nilotinib

arrow
Luxepack
Not Confirmed